Page last updated: 2024-11-03

rizatriptan and Cephalgia Syndromes

rizatriptan has been researched along with Cephalgia Syndromes in 1 studies

rizatriptan: structure given in first source; RN given refers to benzoate

Research Excerpts

ExcerptRelevanceReference
"Chronic migraine (CM) is a common disorder, affecting 2% to 3% of the general population."1.34Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. ( Cavalheiro, EA; Naffah-Mazzacoratti, Mda G; Peres, MF; Senne Soares, CA; Vieira, DS; Zukerman, E, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vieira, DS1
Naffah-Mazzacoratti, Mda G1
Zukerman, E1
Senne Soares, CA1
Cavalheiro, EA1
Peres, MF1

Other Studies

1 other study available for rizatriptan and Cephalgia Syndromes

ArticleYear
Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.
    Headache, 2007, Volume: 47, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Glutamic Acid; Headache Disorders; Headache D

2007